Khartis Therapeutics

Funding reported, Series B, last update 3 days ago

Pharma biotech

Everything we hold on Khartis Therapeutics, newest first. Every line links to the filing or report it came from.

This profile is thin because we hold one source document on Khartis Therapeutics so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.

1. 2026-08-13
   Headcount Not Stated Growing and expanding

   Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs

   Khartis Therapeutics raised $50M in Series B for oral immunology drugs. The announcement does not disclose hiring plans; watch its careers page for pharma and biotech roles.

   $50M raised · News Report · Ventureburn · No archive snapshot yet. We re-check weekly; next check by Aug 23.

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker